Results 161 to 170 of about 12,119 (223)

Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan. [PDF]

Jpn J Ophthalmol
Takahashi Y, Kezuka T, Shikishima K, Yamagami A, Chuman H, Nakamura M, Ueki S, Kimura A, Hashimoto M, Tatsui S, Mashimo K, Ishikawa H.   +11 more
europepmc   +1 more source

Efficacy of human umbilical cord mesenchymal stem cell in the treatment of neuromyelitis optica spectrum disorders: an animal study. [PDF]

Stem Cell Res Ther
Xue C, Yu H, Pei X, Yao X, Ding J, Wang X, Chen Y, Guan Y.   +7 more
europepmc   +1 more source

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort. [PDF]

Neurology
Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Skuljec J, Revie L, Giglhuber K, Häußler V, Karenfort M, Hellwig K, Paul F, Bellmann-Strobl J, Otto C, Ruprecht K, Ziemssen T, Emmer A, Rothhammer V, Nickel FT, Angstwurm K, Linker R, Laurent SA, Warnke C, Jarius S, Korporal-Kuhnke M, Wildemann B, Wolff S, Seipelt M, Yalachkov Y, Retzlaff N, Zettl UK, Rommer PS, Kowarik MC, Wickel J, Geis C, Hümmert MW, Trebst C, Senel M, Gold R, Klotz L, Kleinschnitz C, Meuth SG, Aktas O, Berthele A, Ayzenberg I, German Neuromyelitis Optica Study Group (NEMOS).   +45 more
europepmc   +1 more source

Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis. [PDF]

Eur J Neurol
Klyscz P, Vigiser I, Solorza Buenrostro G, Motamedi S, Leutloff CJ, Schindler P, Schmitz-Hübsch T, Paul F, Zimmermann HG, Oertel FC.   +9 more
europepmc   +1 more source

Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review. [PDF]

Front Neurol
Rodin RE, Chitnis T.
europepmc   +1 more source

Neuromyelitis optica spectrum disorder

, 2012
openaire   +1 more source

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort. [PDF]

Eur J Neurol
Samadzadeh S, Oertel FC, Salih H, Lin TY, Motamedi S, Chien C, Cook LJ, Lana-Peixoto MA, Fontenelle MA, Kim HJ, Hyun JW, Jung SK, Palace J, Roca-Fernandez A, Leite MI, Sharma SM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, Dcunha A, Aktas O, Ringelstein M, Albrecht P, May EF, Tongco C, Leocani L, Pisa M, Radaelli M, Sánchez-Dalmau B, Martinez-Lapiscina EH, Stiebel-Kalish H, Hellmann MA, Lotan I, Siritho S, de Seze J, Senger T, Havla J, Marignier R, Tilikete CF, Cobo-Calvo A, Bichuetti D, Tavares IM, Soelberg K, Altintas A, Yildirim R, Tanriverdi U, Jacob A, Huda S, Rimler Z, Reid A, Mao-Draayer Y, Villoslada P, de Castillo IS, Green A, Petzold A, Yeaman MR, Smith TJ, Brandt AU, Zimmermann HG, Paul F, Asgari N, Guthy Jackson Charitable Foundation – International Clinical Consortium and CROCTINO Collaborators.   +63 more
europepmc   +1 more source

Comparison of inebilizumab or rituximab in addition to glucocorticoid therapy for neuromyelitis optica spectrum disorders. [PDF]

Int J Ophthalmol
Lou CY, Wang Y, Xing JY, Ma T, Tao L, Wang XT, Wang RS.   +6 more
europepmc   +1 more source

Nocardia farcinica pneumonia complicated by pneumocystis jiroveci infection in children with Neuromyelitis Optica Spectrum Disorders: a case report and literature review. [PDF]

Ital J Pediatr
Liu L, Huang Y, Shu S, Zhou H, Fang F, Liu X.   +5 more
europepmc   +1 more source